Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05408338 · ClinicalTrials.gov registry record · NA
Acute Effects of Added Sugar Intake on Cerebrovascular Function and Brain Integrity
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05408338: Completed NA study, sponsored by University of Delaware.
NCT05408338 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05408338, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will focus on acute effects of added sugars on brain health in a specific age group (30-64 years old). We will provide participants two meals (one meal containing 16 g of added sugars and the other containing 61 g of added sugars) and examine blood vessel function and brain structure using a MRI.
Primary Outcome
% change in total cerebral perfusion measured using pseudo-continuous arterial spin labeling in response to 3-minutes of hypercapnia (+9 mmHg increase in PETCO2)
Interventions
- OTHER Low Added Sugar Meal
- OTHER High Added Sugar Meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-06-14 |
| Est. Completion | 2023-04-17 |
| Phase | NA |
What the finished NCT05408338 record still lists
NCT05408338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Added Sugar Meal is the first listed.
NCT05408338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05408338 about?
NCT05408338 is a clinical study titled "Acute Effects of Added Sugar Intake on Cerebrovascular Function and Brain Integrity". This study will focus on acute effects of added sugars on brain health in a specific age group (30-64 years old). We will provide participants two meals (one meal containing 16 g of added sugars and the other containing 61 g of added sugars) and examine blood vessel function and brain structure usin...
What is the current status of trial NCT05408338?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-06-14. Estimated completion is 2023-04-17.
What interventions are being tested in trial NCT05408338?
The interventions under investigation include: Low Added Sugar Meal (OTHER), High Added Sugar Meal (OTHER).
Who is sponsoring clinical trial NCT05408338?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05408338's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI